Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

• Hoofdauteurs: Anjay Rastogi (Auteur), Ashté Collins (Auteur), Ellie Kelepouris (Auteur), Wayne Kotzker (Auteur), John P. Middleton (Auteur), Minesh Rajpal (Auteur), Prabir Roy-Chaudhury (Auteur), Glenn M. Chertow (Auteur)
• Formaat: Boek
• Gepubliceerd in: SAGE Publishing, 2024-08-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Introduction: There remains an unmet need to reduce kidney and cardiovascular risk in patients with chronic kidney disease (CKD). This report is therefore intended to provide real-world clinical guidance to primary care providers on sodium-glucose co-transporter-2 (SGLT2) inhibitor use in patients w...